Caprock Group’s NRC Health Common Stock NRC Stock Holding History

Caprock Group’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-8,575	Closed	-$374K	–	682
2023 Q1	$374K	Buy	+8,575	New	+$379K	0.03%	430

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caprock Group's NRC Position: Q2 2023 in Review

Caprock Group sold out of NRC Health Common Stock (NRC) in Q2 2023, closing a stake of 8,575 shares — an estimated $374K sold.

Caprock Group first reported a position in NRC in Q1 2023 and held it in 1 quarter. The position peaked at $374K in Q1 2023. 116 funds tracked by Wall St. Rank hold NRC as of Q2 2023.

Caprock Group reported no remaining NRC Health Common Stock position as of Q2 2023 after selling out during the quarter.
Caprock Group sold 8,575 NRC Health Common Stock shares in Q2 2023, an estimated $374K.
Caprock Group first reported a position in NRC Health Common Stock in Q1 2023 and held it in 1 quarter.
Caprock Group's NRC Health Common Stock position peaked at $374K in Q1 2023.
116 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2023.

Based on Caprock Group's 13F filing for Q2 2023, filed 10 Aug 2023.